Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada - Wikidata - wikimedia - TriplyDB

Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada

Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada

http://www.wikidata.org/entity/Q34529041

about

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins Behavioral and socioeconomic risk factors associated with probable resistance to ceftriaxone and resistance to penicillin and tetracycline in Neisseria gonorrhoeae in Shanghai High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae.Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance.Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae.Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardship.Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains from Shandong Province, China Utility of specimens positive for Neisseria gonorrhoeae by the Aptima Combo 2 assay for assessment of strain diversity and antibiotic resistance Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada.Update on Treatment Options for Gonococcal Infections.Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.Molecular epidemiology and mechanisms of resistance of azithromycin-resistant Neisseria gonorrhoeae isolated in France during 2013-14.Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Real-Time PCR Targeting penA Mosaic XXXIV Type for Prediction of Extended-Spectrum Cephalosporins Susceptibility in Clinical Neisseria gonorrhoeae Isolates.Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.Determination of In Vitro Activities of Solithromycin at Different pHs and Its Intracellular Activity against Clinical Isolates of Neisseria gonorrhoeae from a Laboratory Collection.Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance.Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.Increasing Resistance to Azithromycin in Neisseria gonorrhoeae in Eastern Chinese Cities: Resistance Mechanisms and Genetic Diversity among Isolates from Nanjing.First description of a cefixime- and ciprofloxacin-resistant Neisseria gonorrhoeae isolate with mutations in key antimicrobial susceptibility-determining genes from the country of Georgia.

P2860

Q24633203-E069363E-9E65-4B4E-88F0-6F439850971D Q26782567-3B905175-0DB3-459E-B522-E894961525F2 Q26862597-6F608162-386B-47C7-90BC-DC12691E98E0 Q28080009-1AD40155-433C-40E6-9643-9F6904A029D0 Q33730287-102CA9EE-E2CD-44EC-9CF5-0ADE69CB083C Q33836057-6C7C12A5-329A-47EA-8510-17BAAEF19835 Q34529360-71AD6552-41AA-4E15-8B8C-E09C48D1BDC5 Q34677116-5C39289F-0C03-4E01-8E90-7D230C6762D6 Q35102691-DE96CAB8-41E8-43E3-B364-61F7E3C4E9B5 Q35107368-ED008CC8-1E91-4A7F-B07D-C72F65475806 Q35806206-6E95BBAF-157B-4446-9465-D8B072EFB917 Q35806407-CF1AAF77-91FB-429C-95AC-89EC3D42B8AA Q35928405-FF303F0B-CC67-4311-9498-491B0EA629AA Q36154055-2DC730DF-893B-42AC-B567-302E3DEEA711 Q36414008-8AA9C709-B42E-4231-A1E1-6320400DF1EE Q36620937-0A1E88AE-895C-4688-832C-0B075D739156 Q36998166-202D116F-E59F-4673-8BF0-961E28C46090 Q37192145-3B7BE897-772A-4550-A076-D4C2F23A4244 Q37244570-1EF434A8-8479-4BC4-99AA-728E3BD9A9E1 Q37336216-CD30EC10-7919-4522-8312-F29829E928A6 Q37358772-B3BDE256-DA6E-4189-841C-01102573A909 Q37539227-B4F6CB18-31C3-45C1-9678-44960052EF86 Q37554132-2F6479A1-5BC2-4099-BE7C-BE16BC852456 Q37713027-8AEFDAE7-531C-4C07-9C1F-74985572A6A1 Q38581807-D5EB8951-205B-4263-8851-ABE101448543 Q38652213-0C47E28B-35E3-4E31-AA9E-809681B1CAAC Q38900941-F535525B-55E0-47C8-B007-8E5320898505 Q39054852-A363CF6E-8987-4852-925F-D2C055D68284 Q39108153-B185DA29-B09A-44C8-9D4D-B324C4F59146 Q40067386-895C2AC3-0227-4B30-BBFF-902DDCC9AAE0 Q40648247-52B88E3D-FF3A-41BA-9F53-47E4685ACF6A Q41571565-43061B65-07D9-4183-847B-5811C55AA66A Q42228137-DDA61FD1-F75F-4D69-B56F-146632B2EA0F Q42229463-CB451F26-D1E9-4A4D-BD68-25FD4D07905E Q42573047-3A1E1657-6F27-4113-AF65-C99932B05FBC Q42762431-3BC94742-3467-4ABE-A74E-1C4FBD7A8EF2 Q53698098-B67C352E-1308-406E-88CF-E6FECAC730BB Q54311156-C5083CCE-4B13-4124-A2F5-727D6CAEFB31 Q55002553-16702365-2242-423A-AA8D-0312A6E01F9C Q55382601-73F2CF16-8FB8-415F-83DD-B181C8842338

P2860

Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada

http://www.wikidata.org/entity/Q34529041

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@ast

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@en

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@nl

type

label

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@ast

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@en

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@nl

prefLabel

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@ast

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@en

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@nl

P1433

Q34529041-687731EF-267F-4288-91D7-96D4A52EC9F2

P1476

Q34529041-18ACAF1B-F0FA-4B6D-B58F-3D911DDF6804

P2093

Q34529041-077E7375-1523-4303-910F-A9646AF71B19

Q34529041-222681EE-B46A-4C44-9D81-C24138492A00

Q34529041-273DAF1B-18A7-468B-8D95-916B4B4BC39D

Q34529041-3CBF87CE-340D-4BB2-BF3D-F36DB668E4A7

Q34529041-4E4F8A8E-E361-4363-83E0-C7DA00D8658C

Q34529041-747256D9-3FA2-4E8D-A0D4-52AB5F2ECAE0

Q34529041-7728B2A9-0901-4099-8B1D-84F090BF5773

Q34529041-7E18597C-5C9D-4ECB-88BC-069064C59BEE

P2860

Q34529041-02A1AF69-91AD-44FC-A899-0064F03D3F3E

Q34529041-0B86BC64-FFB2-4C9A-AB55-FBD3A165BB4B

Q34529041-1BBD423A-F16A-4C4A-AA0F-B45065B1A75D

Q34529041-279F3A2E-DE11-42BE-AC04-E824F7F94AF0

Q34529041-2A4ED275-25BC-41C9-8748-13AC9746FE46

Q34529041-358DDF20-6316-4A52-8B52-A0972E5B319F

Q34529041-362B3481-DF51-48F6-88BC-3025C8157199

Q34529041-37AE1E3B-4D10-4D87-A967-B1E02737F964

Q34529041-3DCA4BFA-6BE6-420F-AFD0-2590FC24EC9D

Q34529041-4269F896-30BE-413B-BE88-27800CC750E2

P304

Q34529041-264A8DCE-C1C0-4417-841E-308C834B0C2C

P31

Q34529041-2A677893-B418-4447-90E7-D3FE669E6743

P356

Q34529041-3ED05672-732A-448E-B64E-57A3167E6C70

P407

Q34529041-290DB4B9-96D5-4C11-90AA-C1C52DEAA2B0

P433

Q34529041-32C9202C-0673-4372-975F-B845EA658449

P478

Q34529041-B5F500D9-7655-4082-85E2-8B702279823B

P50

Q34529041-0B45AA31-CF34-4E74-9B02-D6D8EE1FC103

Q34529041-A01FED96-8F6D-427D-8859-BF3634248B57

P577

Q34529041-AD8539C9-DD11-4043-ABB7-FF1154F2A1EA

P5875

Q34529041-593591FD-93BB-4CB5-8342-045F236E44A4

P698

Q34529041-753BF335-EC99-4802-B07C-760300F3EDD4

P921

Q34529041-206A0CAE-CE43-4E71-8AF0-D8BD95B6AB6F

Q34529041-81DD2502-2284-4807-8E60-B96E1B451F4E

Q34529041-E79768E3-506D-4692-A8C4-E9CBFDE910B6

P932

Q34529041-42634483-65EA-4E4B-87F7-EA308D2AF355

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Molecular analysis of antimicr ...... isolates from Ontario, Canada

@en

P2093

Anuradha Rebbapragada

http://www.w3.org/2001/XMLSchema#string

David J Farrell

http://www.w3.org/2001/XMLSchema#string

Jingyuan Tan

http://www.w3.org/2001/XMLSchema#string

Lynn Towns

http://www.w3.org/2001/XMLSchema#string

Nathalie Tijet

http://www.w3.org/2001/XMLSchema#string

Stephen J Perusini

http://www.w3.org/2001/XMLSchema#string

Stephen Lo

http://www.w3.org/2001/XMLSchema#string

Vanessa G Allen

http://www.w3.org/2001/XMLSchema#string

P2860

Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections

Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains

Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages.

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes

Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA.

High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants

High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.

Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae.

P304

703-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00788-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Roberto G.Melano

P577

2010-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49629411

http://www.w3.org/2001/XMLSchema#string

P698

21098249

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria gonorrhoeae

antimicrobial resistance

P932

3028768

http://www.w3.org/2001/XMLSchema#string